cvm_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported):  May 19, 2025

 

CEL-SCI CORPORATION

(Exact name of Registrant as specified in its charter)

 

Colorado

 

001-11889

 

84-0916344

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

 

8229 Boone Blvd., #802

Vienna, VA 22182

(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code:(703) 506-9460

 

N/A

(Former name or former address if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c))

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock

 

CVM

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Securities Holders.

 

The annual meeting of CEL-SCI’s shareholders was held on May 19, 2025. At the meeting the following persons were elected as directors for the upcoming year:

 

 

Name

 

Votes For

 

Votes Against

 

Broker Non-Votes

 

Geert Kersten

 

21,571,997

 

4,878,281

 

18,092,130

 

Bruno Baillavoine

 

16,278,124

 

10,172,154

 

18,092,130

 

Robert Watson

 

16,672,564

 

9,777,714

 

18,092,130

 

At the meeting the following were approved by CEL-SCI’s shareholders:

 

 

(2)

the adoption of CEL-SCI’s 2025 Non-Qualified Stock Option Plan; and

 

 

 

 

(3)

the adoption of CEL-SCI’s 2025 Stock Bonus Plan; and

 

 

 

 

(4)

the combination of CEL-SCI’s common stock; and

 

 

 

 

(5)

the appointment of BDO USA, P.C. as CEL-SCI’s independent registered public accounting firm for the fiscal year ending September 30, 2025.

 

The following is a tabulation of votes cast with respect to proposals 2 through 5:

 

 

Proposal

 

Votes For

 

Votes Against

 

Abstain

 

Broker Non-Votes

 

(2)

 

18,096,468

 

8,088,876

 

264,934

 

18,092,130

 

(3)

 

17,857,852

 

8,208,995

 

383,431

 

18,092,130

 

(4)

 

28,279,258

 

15,613,723

 

649,427

 

-

 

(5)

 

40,219,973

 

3,543,525

 

778,910

 

-

 

 

2

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 Date:  May 19, 2025 

CEL-SCI CORPORATION

 

 

 

 

 

 

By:

/s/Geert Kersten

 

 

 

Geert Kersten

 

 

 

Chief Executive Officer

 

  

 

3